Key statistics
As of last trade, Marinus Pharmaceuticals Inc (61Y:STU) traded at 0.29, 10.69% above the 52 week low of 0.262 set on Oct 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.286 |
---|---|
High | 0.29 |
Low | 0.286 |
Bid | 0.292 |
Offer | 0.314 |
Previous close | 0.288 |
Average volume | 13.33 |
---|---|
Shares outstanding | 55.08m |
Free float | 49.06m |
P/E (TTM) | -- |
Market cap | 17.75m USD |
EPS (TTM) | -2.47 USD |
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Press releases
- Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results
- Marinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic Alternatives
- Marinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 RAISE Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual Meeting
- Marinus Pharmaceuticals Further Strengthens Intellectual Property Estate with Method of Treatment Patent for ZTALMY® Titration Regimens
- Marinus Pharmaceuticals Announces Podium and Poster Presentations at the Neurocritical Care Society 2024 Annual Meeting
- Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
- Marinus Pharmaceuticals to Highlight Clinical Progress and Commercial Launch Preparedness for ZTALMY® in TSC at Investor and Analyst Day
- Marinus Pharmaceuticals Announces Agenda and Speakers for Investor & Analyst Day on September 20, 2024
- Marinus Pharmaceuticals to Present at the 2024 Cantor Global Healthcare Conference
More ▼